Glenmark Pharma receives ANDA approval for nitroglycerin sublingual tablets
IMS Health estimates annual sales of approx $112.7 million for these three strenghts of Nitrostat® Sublingual Tablets
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.